Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05725967 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endoscopic Metabolic and Bariatric Therapies

Study acronym: EMBTs
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 8, 2026 to May 28, 2028
    • Study completion date: Dec 31, 2026 to May 28, 2029
    v3
  2. Primary completion date: Jul 8, 2025 to Jul 8, 2026
    • Primary endpoints revised (13)
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.
Trial Details
NCT Number NCT05725967
Lead Sponsor Christopher C. Thompson, MD, MSc
Conditions
(from sponsor)		 Obesity, Obesity, Morbid, Obesity Associated Disorder, Bariatric Surgery Candidate, Fistula, Gastric, Roux-en-y Anastomosis Site, Ulcer, Gastric, Abdominal Pain +8 more
Related terms Abdominal Pain, Anastomotic Leak, Gastric Fistula, Obesity, Obesity, Abdominal, Obesity, Morbid, Postoperative Complications, Stomach Ulcer, Weight Gain, Weight Loss
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov